Primary Site >> Liver Cancer

Gene >> ACVRL1

Journal: Oncotarget. 2015 Jul 10;6(19):17379-90.
Title: Novel roles of TMEM100: inhibition metastasis and proliferation of hepatocellular carcinoma.
Author: Ou, Dipeng|Yang, Hao|Hua, Dong|Xiao, Shuai|Yang, Lianyue
PMID: 25978032
Journal: J Virol. 2017 Oct 13;91(21). pii: JVI.01235-17.
Title: Hepatitis C Virus Core Protein Modulates Endoglin (CD105) Signaling Pathway for Liver Pathogenesis.
Author: Kwon, Young-Chan|Sasaki, Reina|Meyer, Keith|Ray, Ranjit
PMID: 28794048
Journal: Bioorg Med Chem. 2017 Oct 15;25(20):5637-5651.
Title: Pyrrolizines: Design, synthesis, anticancer evaluation and investigation of the potential mechanism of action.
Author: Gouda, Ahmed M|Abdelazeem, Ahmed H|Omar, Hany A|Abdalla, Ashraf N|Abourehab, Mohammed A S|Ali, Hamed I
PMID: 28916158
Journal: Oncologist. 2018 Oct 23. pii: theoncologist.2018-0654.
Title: A Phase Ib, Open-Label Study of Dalantercept, an Activin Receptor-Like Kinase 1 Ligand Trap, plus Sorafenib in Advanced Hepatocellular Carcinoma.
Author: Abou-Alfa, Ghassan K|Miksad, Rebecca A|Tejani, Mohamedtaki A|Williamson, Stephen|Gutierrez, Martin E|Olowokure, Olugbenga O|Sharma, Manish R|El Dika, Imane|Sherman, Matthew L|Pandya, Shuchi S
PMID: 30352941